menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Macleods`s Generics Valsartan, HCTZ Receives Approval in US

    FDA

    Novartis loses latest bid to block generic version of blockbuster heart drug

    REUTERS

    USV launches heart failure medication at 8rs per 50mg tablet

    EXPRESSPHARMA

    Macleods`s Generics Amlodipine, Valsartan Receives Approval in US

    FDA

    Novartis loses initial bid to block generic of best-selling heart drug

    REUTERS

    Zenara`s Generics Valsartan Receives Approval in US

    FDA

    EDQM issued CEP Certificate for “Valsartan”

    PRESS RELEASE

    Zydus Life hits 52-week high on USFDA nod for Sacubitril and Valsartan

    ECONOMIC TIMES

    Zydus Pharms Generic Sacubitril :Valsartan Receives Approval in US

    FDA

    Amneal`s Generic Valsartan & Hydrochlorothiazide Receives Approval in the U.S.

    FDA

    Novartis heart drug price may fall by 60% on generic rollouts

    ECONOMIC TIMES

    Dr Reddy`s cuts price of cardiovascular drug Cidmus

    ECONOMIC TIMES

    HC reserves order on Natco`s plea over patent for Novartis drug

    ECONOMIC TIMES

    Novartis pays $245M to settle Exforge generic pay-for-delay suit

    FIERCE PHARMA

    Top Novartis cardiac drug to go off patent

    ECONOMICTIMES

    IOL Chemicals secures patent for invention related to preparation of Sartan drugs

    BUSINESS-STANDARD

    Prompted by recent recalls, regulators scramble to address novel nitrosamines

    RAPS

    Prinston`s Generic Nebivolol HCL, Valsartan Receives Approval in the U.S.

    FDA

    Novartis files FDA appeal in bid to block Entresto generics

    FIERCEPHARMA

    Dr. Reddy`s Announces the Launch of Valsartan Tablets, USP in the U.S. Market

    BUSINESSWIRE

    Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia

    FIERCEPHARMA

    Novitium Pharma`s Generic Valsartan Receives Approvals in US

    FDA

    Delhi HC restrains generic firms from making, selling patent drug of Novartis

    ECONOMICTIMES

    ScieGen Pharma`s Generic ValsartanReceives Approval In US

    FDA

    ScieGen Pharma`s Generic ValsartanReceives Approval In US

    FDA

    Dr. Reddy`s Generics Valsartan Receives Approval in US

    FDA

    Multiple lots of irbesartan, losartan and valsartan drugs recalled

    NEWSWIRE

    Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs

    HEALTH CANADA

    Novartis Entresto® indicated for treatment of hypertension in China

    PRESS RELEASE

    Health Canada Issues Recall of Sandoz Canada`s Valsartan

    HEALTH CANADA

    Sacubitril/valsartan not superior to valsartan alone in advanced HFrEF: LIFE

    HEALIO

    Novartis whiffs on Entresto study after heart attacks that doesn`t going down

    ENDPTS

    Novartis` Entresto came up short in a post-heart attack phase 3

    FIERCEPHARMA

    FDA reviewers argue for Novartis ahead of Entresto advisory panel confab

    FIERCEPHARMA

    It Paid Doctors Kickbacks. Now, Novartis Will Pay a $678 Million Settlement.

    NYTIMES

    AI VIVO seeks pharma, biotech collaboration partners to advance drug candidates

    MEDICAL

    Cosentyx, Entresto drive topline growth for Novartis in Q4

    PMLIVE

    Industry faces new risks from old drugs, more testing in 2020

    FIERCE PHARMA

    Sun Pharma gets partial relief from US court in litigation on generic drugs

    BUSINESS-STANDARD

    Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF

    PR NEWSWIRE

    6 Major Drug Recalls from the Past

    BIOSPACE

    FDA tags Torrent as key offender in production of tainted blood pressure meds

    FIERCE PHARMA

    Mylan to invest $1 billion in India on capex in 6 years

    THE ECONOMIC TIMES

    FDA Confirms Paragraph IV Patent Challenge of Entresto 207620 (Sacubitril and Valsartan)Tablets 24 mg/26 mg, 49 mg/51 mg , 97 mg/103 mg

    FDA

    FDA finds impurity in popular heartburn medicine Zantac that could cause cancer

    CNBC

    US officials worried about Chinese control of American drug supply

    NBCNEWS

    EMA, FDA Begin Reviewing Heartburn Medicines for Carcinogen

    RAPS

    Aurobindo recalls mislabeled statin tablets from the U.S. market

    FIERCE PHARMA

    Square Pharma`s Generic Valsartan Receives Approval in US

    FDA

    FDA says widening probe on generic drug impurities

    REUTERS

    The sartan saga: Recapping the recalls

    IN-PHARMATECHNOLOGY

    NDEA & NDMA Impurities: Another Indian Manuf. Receives an FDA Warning Letter

    RAPS

    Novartis` Entresto falls short at Ph 3 in heart failure with preserved ejection

    PHARMAFILE

    US FDA finds "significant violations" at India`s Strides plant

    ECONOMIC TIMES

    Manufacturing Concerns Lead FDA to Pull 31 Apotex ANDAs

    RAPS

    FDA Sends Warning Letters to Aurobindo, API Repackers

    RAPS

    Aurobindo gets warning letter over valsartan recall mess

    FIERCE PHARMA

    Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS

    FIERCE PHARMA

    Pharmacy takes FDA to task in citizen petition over tainted valsartan

    FIERCE PHARMA

    Fourth Carcinogen Discovered in Heart Pills Used by Millions

    BLOOMBERG

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.